CME Group Inc. 8-K Summary
Business Context and Reporting Period
CME Group Inc. filed a Current Report on Form 8-K on February 4, 2026. The filing reports financial results for the quarter and full year ended December 31, 2025. The company is incorporated in Delaware and trades on the Nasdaq under the symbol CME.
Key Financial Metrics
The filing references a press release (Exhibit 99.1) containing detailed financial results but does not explicitly state specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity within the 8-K text itself. The report includes both GAAP and non-GAAP financial measures, including non-GAAP revenues, expenses, operating income, net income, and earnings per share.
Material Changes
The filing text does not provide specific data points to quantify material changes versus the prior comparable period. It notes that management believes non-GAAP measures provide better comparability with prior financial reports.
Guidance, Outlook, and Risks
The filing does not contain explicit forward-looking guidance, outlook statements, or specific risk factors in the provided text. It includes a standard disclaimer that the information in Item 2.02 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Management acknowledges that non-GAAP adjustments may include recurring items and should be viewed as a supplement to, not a substitute for, GAAP measures.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 4, 2026) for specific revenue, earnings, and cash flow figures.
- Examine the reconciliation of non-GAAP financial measures to GAAP measures included in the press release.
- Verify the specific year-over-year and quarter-over-quarter percentage changes in operating income and net income.
- Confirm details on debt levels and liquidity positions as reported in the full press release.